Nutex Health (NUTX) Equity Ratio (2010 - 2026)

Nutex Health has disclosed Equity Ratio across 17 years of filings, most recently posting 0.46 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.46, up 37.83% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.46 (up 37.83% YoY), and the FY2025 annual result was 0.46, up 60.24% from the prior year.
• Equity Ratio came in at 0.46 for Q1 2026 at Nutex Health, roughly flat from 0.46 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 2.25 in Q1 2022 to a low of 0.18 in Q3 2024.
• The 5-year median for Equity Ratio is 0.29 (2024), against an average of 0.43.
• Across the five-year window, Equity Ratio tumbled 88.68% in 2023 and soared 149.62% in 2025, its largest moves.
• Nutex Health's Equity Ratio stood at 0.28 in 2022, then dropped by 28.73% to 0.2 in 2023, then jumped by 44.84% to 0.29 in 2024, then jumped by 60.24% to 0.46 in 2025, then increased by 0.17% to 0.46 in 2026.
• The last three Equity Ratio figures came in at 0.46 (Q1 2026), 0.46 (Q4 2025), and 0.45 (Q3 2025), per Business Quant data.